Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations

Hematopoietic stem cell transplantation (HSCT) is effective therapy for patients with chronic myelogenous leukemia (CML) but is now mostly indicated for patients who develop resistance to tyrosine kinase inhibitors (TKIs), which can be associated with point mutations in BCR-ABL1. We reviewed the out...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jabbour, Elias, Cortes, Jorge, Santos, Fabio P. S., Jones, Dan, O'Brien, Susan, Rondon, Gabriela, Popat, Uday, Giralt, Sergio, Kebriaei, Partow, Jones, Roy B., Kantarjian, Hagop, Champlin, Richard, de Lima, Marcos
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2011
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4186643/
https://ncbi.nlm.nih.gov/pubmed/21156844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-08-302679
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados